Telomeres Might Predict Lung Cancer Recurrence
Telomeres are sections of DNA that tell an interesting story about lifespan. Shorter telomeres usually suggest a shorter life -- but new research by a Wilmot lung cancer expert shows that longer telomeres might be a promising biomarker for a recurrence of early stage lung cancer.
The 26th Annual Genetics Day 2014, held recently at the university campus had an extra special keynote lecture by one of the latest Nobel Laureates. Additionally, there were research talks by faculty members and posters by students and trainees. The afternoon saw a special session of remembering longtime University faculty member and legendary geneticist Fred Sherman.
6/12/2014 | 0 comments
Companions often speak on behalf of patients during discussions of cancer treatment and prognosis, even when the patient is present and capable of speaking on his or her own behalf, according to a new study by the Wilmot Cancer Institute and UR Family Medicine.
6/11/2014 | 0 comments
One of the big topics in cancer research is immunotherapy and the need for a new generation of drugs that spur the immune system to fight tumors. John Frelinger’s lab was featured in a news article in the journal Nature, for its work on refining interleukin-2.
6/4/2014 | 0 comments
A recent study by University of Rochester School of Medicine and Dentistry researchers published in the International Journal of Geriatric Psychiatry begins to unravel the relationship between metabolic syndrome, frailty and cognition. The authors found that having metabolic syndrome significantly increased the chances of becoming physically frailer and slower in cognitive abilities, such as slower in recalling something that happened half an hour ago.
6/4/2014 | 0 comments
HIV-associated brain damage occurs extensively, even in patients who are taking otherwise effective traditional anti-HIV therapy. This is a result of potent cooperation between two types of special immunological cells within the brain called monocytes and platelets. A recent paper published by University researchers in the Journal of Immunology demonstrates the presence of these platelet-monocyte ‘teams’ in HIV infected individuals and how these teams lead to increased neuronal damage.
6/3/2014 | 2 comments